Prognosis value of microscopic bile duct invasion in hepatocellular carcinoma: A multicenter study

Cancer Med. 2023 Nov;12(22):20821-20829. doi: 10.1002/cam4.6650. Epub 2023 Nov 1.

Abstract

Objective: To evaluate the prognostic significance of microscopic bile duct invasion (MiBDI) in hepatocellular carcinoma (HCC) following R0 resection.

Patients and methods: Patients who underwent R0 resection for HCC at nine medical centers were stratified into five groups: neither bile duct nor vascular invasion (MiBDI-MVI-), microscopic bile duct invasion alone (MiBDI+MVI-), both microscopic bile duct and vascular invasion (MiBDI+MVI+), microscopic vascular invasion alone (MiBDI-MVI+), and macroscopic bile duct invasion (MaBDI). Overall survival (OS) was assessed using Kaplan-Meier analysis, and independent risk factors of OS were determined using Cox proportional hazards models.

Results: A total of 377 HCC cases were analyzed. The OS for MiBDI+MVI- was similar to that of MiBDI-MVI- (p > 0.05) but better than MiBDI+MVI+, MiBDI-MVI+, and MaBDI (all p < 0.05). Multivariate analysis indicated that MiBDI was not an independent risk factor for OS, while MVI and MaBDI were.

Conclusions: Overall survival (OS) in patients with MiBDI was superior to those with MVI and MaBDI. Isolated MiBDI did not influence OS in patients with HCC after R0 resection.

Keywords: bile duct invasion; hepatocellular carcinoma; survival; vascular invasion.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bile Ducts / pathology
  • Bile Ducts / surgery
  • Carcinoma, Hepatocellular* / pathology
  • Hepatectomy
  • Humans
  • Liver Neoplasms* / pathology
  • Neoplasm Invasiveness / pathology
  • Prognosis
  • Retrospective Studies